Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Journal of Neuro-Oncology|April 13, 2023
Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study GroupShinji Yamashita, Hideo Takeshima, Nobuhiro Hata, et al.
Cancers|April 3, 2021
Fine-Tuning Approach for Segmentation of Gliomas in Brain Magnetic Resonance Images with a Machine Learning Method to Normalize Image Differences among FacilitiesSatoshi Takahashi, Masamichi Takahashi, Manabu Kinoshita, et al.
Neuro-Oncology|November 5, 2022
Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114CKazuhiko Mishima, Ryo Nishikawa, Yoshitaka Narita, et al.
NPJ Digital Medicine|May 5, 2026
Comparing artificial intelligence and physician performance in predicting IDH mutation status in gliomaSatoshi Takahashi, Masamichi Takahashi, Manabu Kinoshita, et al.
Neuro-Oncology|November 4, 2024
Phase II trial of pathology-based tripartite treatment stratification for patients with CNS germ cell tumors: A long-term follow-up studyHirokazu Takami, Masao Matsutani, Tomonari Suzuki, et al.
Neuro-Oncology|August 21, 2020
So-called bifocal tumors with diabetes insipidus and negative tumor markers: are they all germinoma?Masayuki Kanamori, Hirokazu Takami, Shigeru Yamaguchi, et al.
Neuro-Oncology Advances|August 6, 2021
Necessity for craniospinal irradiation of germinoma with positive cytology without spinal lesion on MR imaging-A controversyMasayuki Kanamori, Hirokazu Takami, Tomonari Suzuki, et al.
Acta Neuropathologica Communications|August 10, 2016
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomasHideyuki Arita, Kai Yamasaki, Yuko Matsushita, et al.
Pageof 9